Shilpa Medicare Limited has informed the Exchange about General Updates regarding Revised attachment to Annexure I., on Execution of Agreement with NXI Therapeutics AG
SHILPAMED · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Shilpa Medicare has submitted a corrected/revised attachment related to its previously disclosed agreement with NXI Therapeutics AG, a Switzerland-based biotech firm. The filing updates Annexure I with corrected information on the terms of the agreement. The original announcement relates to a collaboration or business arrangement between Shilpa Medicare and the foreign biotech company. No fresh financial details or terms are introduced beyond the correction itself.
This is largely a procedural correction to an earlier filing and is unlikely to have a direct material impact on the stock price. Investors should refer to the original announcement for the actual deal terms and strategic significance.